seca Launches mBCA Alpha to Further Integrate Body Composition Screening into Primary Care

NEW YORK--(BUSINESS WIRE)--seca, the global leader in medical measuring and weighing, today announced the latest addition to its line of advanced body composition analyzers, mBCA Alpha (Alpha), a compact, portable scanner specifically designed for use in a primary care setting. This new product further enhances seca's transformation from a measuring and weighing company to a modern technology-first solutions partner, making body composition screenings more accessible to all providers–not just specialists.

Utilizing validated bioelectrical impedance analysis (BIA), Alpha delivers a complete picture of a patient's body composition in just 24 seconds. seca’s Alpha will assist providers in monitoring and flagging health measures such as early signs of excess adiposity, age-related muscle decline, and the total body impact of medications such as GLP-1s. The Alpha scanner is powered by the company’s proprietary Analytics 125 platform, granting healthcare providers access to cloud-based reporting, seca’s Treatment Tracker, and an app for patients that enables real-time data access.

Before the launch of a solution tailored to primary care providers, teams were forced to rely on methods like weight and body mass indexing (BMI) to understand their patients’ risk for chronic conditions like obesity, diabetes, heart disease, and metabolic syndrome, which been criticized as an outdated, misleading, and even racially biased method of measuring health. Alpha’s integration of body composition into primary care allows providers to gather more accurate and previously inaccessible insights into body fat, muscle mass, and visceral fat. This enables care teams to make more data-driven diagnoses, treatment, and long-term health monitoring decisions.

“We are witnessing a clinical transformation as clinicians and patients realize that BMI is no longer enough,” said Nina Crowley, PhD, RD, Director of Clinical Education and Partnerships at seca. “As the industry shifts toward embracing a longitudinal care model that prioritizes precision, personalization, and prevention, we must ensure teams have innovative solutions that allow them to succeed in the care of their patients. Alpha was built to reflect how today’s clinicians work–quickly, accurately, and intuitively.”

Alpha and the rest of seca’s bioimpedance technology solutions are among the most clinically validated in the world, with 97 percent correlation to a whole-body MRI and 98 percent agreement with the gold-standard 4-compartment model for fat mass. By building its solutions on a foundation of scientific rigor, seca ensures that providers make decisions based on the highest-quality data available.

“As a primary care clinician and obesity medicine specialist, I’m a firm believer in the impact regular body composition screenings can have on patient care,” said Dr. Angela Fitch, Co-Founder and Chief Medical Officer of knownwell, a primary care company that uses seca’s body composition scan for patients at its Boston and Dallas clinics. “Rather than reference an outdated measurement like BMI, enabling patients to access body composition scans at their primary care appointments can help them engage in more meaningful conversations with their clinicians about their health goals and appropriate next steps to achieve them, resulting in better treatment outcomes.”

The launch of Alpha follows the company's introduction of Treatment Tracker, an industry-first solution that integrates a patient’s treatment plan with their body composition results on a single platform to monitor clinical interventions, visualize changes, and modify treatment plans in real-time. For more information about seca and its suite of body composition solutions transforming care, please visit www.secambca.com.

About seca

seca, the global leader in medical body composition and weighing solutions, empowers healthcare providers with advanced technology that goes beyond weight and BMI to support comprehensive obesity care. With over 185 years of German engineering, seca sets the standard for precision, innovation, and reliability in medical measurement. Trusted worldwide in obesity medicine, bariatrics, and metabolic health, seca’s scientifically validated body composition analyzers provide clinicians with key insights into fat mass, muscle mass, and hydration—helping optimize patient outcomes. seca’s solutions integrate seamlessly into clinical workflows, ensuring accurate, data-driven care. www.secambca.com.